Merck scraps another late-stage Alzheimer's drug study

loading...


Merck scraps another late-stage Alzheimer’s drug study
NEW YORK (Reuters) – Merck & Co Inc on Tuesday said it will end another late-stage trial of an Alzheimer’s drug because it was unlikely to work, adding to the pile-up of failures to find an effective treatment for the mind-wasting disease.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...